Both in Pharmaceuticals
Relmada Therapeutics vs CorMedix
Over the past year RLMD returned +94.1% and CRMD returned −51.8%; their daily moves had a correlation of 0.07.
RLMD +94.1% CRMD −51.8%Growth of $1, one year, split-adjusted
| Metric | RLMD | CRMD |
|---|---|---|
| Price | $4.27 | $5.56 |
| Market cap | $455.5M | $433.4M |
| Today | +11.20% | +3.15% |
| 1 month | +22.7% | −23.4% |
| 6 months | −41.9% | −28.1% |
| Year to date | −11.6% | −52.2% |
| 1 year | +88.9% | −50.0% |
| Revenue growth (YoY) | — | +156.5% |
| Gross margin | — | 75.7% |
| Net margin | — | 25.5% |
| P/E (TTM) | — | 2.3× |
| Price / sales | — | 0.9× |
| Net cash | $217.7M | $256.7M |
| Dividend yield | — | — |
| Volatility (60d) | 59.9% | 77.3% |
| Short % of float | 14.0% | 20.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).